TherapeuticsMD

TherapeuticsMD operates as a women's health care product company. The Company manufactures and distributes prescription and over-the-counter product lines, including prenatal vitamins, iron supplements, and natural menopause relief products under the vitaMedMD brand, as well as generic formulations of its prescription prenatal vitamins products under the BocaGreenMD Prena1 name. TherapeuticsMD creates products to address the unique changes and challenges women experience through every stage of their lives.
Company Growth (employees)
Type
Public
HQ
Boca Raton, US
Founded
2008
Size (employees)
159 (est)
TherapeuticsMD was founded in 2008 and is headquartered in Boca Raton, US

Key People/Management at TherapeuticsMD

Robert Finizio

Robert Finizio

Chief Executive Officer
Dan Cartwright

Dan Cartwright

Chief Financial Officer
John Milligan

John Milligan

President
Julia Amadio

Julia Amadio

Chief Product Officer
Brian Bernick

Brian Bernick

Co-founder & Chief Clinical Officer
Mitchell Krassan

Mitchell Krassan

Chief Strategy Performance Officer

TherapeuticsMD Office Locations

TherapeuticsMD has an office in Boca Raton
Boca Raton, US (HQ)
6800 Broken Sound Pkwy NW
Show all (1)

TherapeuticsMD Financials and Metrics

TherapeuticsMD Financials

TherapeuticsMD's revenue was reported to be $19.4 m in FY, 2016
USD

Revenue (Q2, 2017)

4.3 m

Gross profit (Q2, 2017)

3.6 m

Gross profit margin (Q2, 2017), %

84%

Net income (Q2, 2017)

(19.7 m)

EBIT (Q2, 2017)

(19.8 m)

Market capitalization (16-Feb-2018)

424.2 m

Cash (30-Jun-2017)

96.5 m
TherapeuticsMD's current market capitalization is $424.2 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

8.8 m15 m20.1 m19.4 m

Revenue growth, %

71%34%(4%)

Cost of goods sold

2 m3.7 m4.5 m4.2 m

Gross profit

6.8 m11.4 m15.6 m15.2 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

2.3 m2.8 m3.8 m4.2 m4.5 m4.8 m5.2 m4.9 m4.4 m5.5 m4 m4.3 m

Cost of goods sold

648.4 k830.7 k893 k1.1 m1 m1 m1.2 m1.1 m1.1 m1.2 m659.6 k681.7 k

Gross profit

1.6 m2 m2.9 m3.1 m3.4 m3.8 m4 m3.8 m3.3 m4.3 m3.3 m3.6 m

Gross profit Margin, %

72%71%76%74%77%79%77%78%74%78%83%84%
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

54.2 m51.4 m64.7 m131.5 m

Inventories

1 m1.2 m690.2 k1.1 m

Current Assets

59.4 m56.2 m70.7 m139.4 m

Total Assets

62 m59.1 m73.7 m142.5 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

59.6 m45.4 m35.6 m67 m67.2 m81.1 m182.1 m166.5 m147.5 m113.5 m96.5 m

Inventories

1.1 m920.7 k1.5 m1 m1.2 m870.1 k957.4 k883.7 k843.4 k1.3 m1.4 m

Current Assets

65.9 m51 m41.8 m72.2 m73 m87.8 m189.8 m174 m156.1 m121.3 m103.5 m

Total Assets

68.5 m53.6 m44.4 m74.6 m75.7 m90.5 m193 m176.6 m158.8 m124.4 m106.9 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(28.4 m)(54.2 m)(85.1 m)(89.9 m)

Depreciation and Amortization

58.1 k52.5 k62.4 k132.5 k

Accounts Receivable

(1.1 m)(458 k)(917.7 k)(4 m)

Inventories

571.6 k(138.5 k)492 k(386.2 k)
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Net Income

(7.7 m)(9.2 m)(10.9 m)(17.8 m)(20.9 m)(48.1 m)(67.6 m)(20.9 m)(42 m)(67 m)(21.2 m)(40.8 m)

Depreciation and Amortization

32.4 k13.1 k14.1 k12.7 k13.6 k27.9 k44.4 k19.6 k24.3 k40.5 k49.7 k

Accounts Receivable

(502.8 k)(1.2 m)(1.5 m)(2.3 m)(1.9 m)(4.2 m)580.9 k1.1 m

Inventories

1.5 m1 m222.9 k(66.6 k)312.1 k(267.3 k)(193.5 k)(153.2 k)(262.3 k)(337.7 k)
Y, 2017

Financial Leverage

1.1 x
Show all financial metrics

TherapeuticsMD Market Value History

TherapeuticsMD's Web-traffic and Trends

TherapeuticsMD Online and Social Media Presence

TherapeuticsMD Company Life and Culture

You may also be interested in